Works matching IS 03403696 AND DT 2020 AND VI 312 AND IP 6


Results: 9
    1
    2
    3
    4
    5

    Etanercept biosimilar (recombinant human tumor necrosis factor-α receptor II: IgG Fc fusion protein) and methotrexate combination therapy in Chinese patients with moderate-to-severe plaque psoriasis: a multicentre, randomized, double-blind, placebo-controlled trial

    Published in:
    Archives of Dermatological Research, 2020, v. 312, n. 6, p. 437, doi. 10.1007/s00403-019-02024-6
    By:
    • Liu, Lun-Fei;
    • Chen, Ji-Su;
    • Gu, Jun;
    • Xu, Jin-Hua;
    • Jin, Hong-Zhong;
    • Pang, Xiao-Wen;
    • Wang, Gang;
    • Yu, Chen;
    • Song, Zhi-Qiang;
    • Guo, Zai-Pei;
    • Li, Wei;
    • Lai, Wei;
    • Cui, Pan-Gen;
    • Chen, Min;
    • Fang, Hong;
    • Lyu, Cheng-Zhi;
    • Li, Yu-Zhen;
    • Sun, Qing;
    • Xie, Hong-Fu;
    • Liu, Xiao-Ming
    Publication type:
    Article
    6
    7
    8
    9